Literature DB >> 27241222

Heparan Sulfate: Biosynthesis, Structure, and Function.

J-P Li1, M Kusche-Gullberg2.   

Abstract

Heparan sulfate (HS) proteoglycans (PGs) are ubiquitously expressed on cell surfaces and in the extracellular matrix of most animal tissues, having essential functions in development and homeostasis, as well as playing various roles in disease processes. The functions of HSPGs are mainly dependent on interactions between the HS-side chains with a variety of proteins including cytokines, growth factors, and their receptors. In a given HS polysaccharide, negatively charged sulfate and carboxylate groups are arranged in various types of domains, generated through strictly regulated biosynthetic reactions and with enormous potential for structural variability. The mode of HS-protein interactions is assessed through binding experiments using saccharides of defined composition in vitro, signaling assays in cell models where HS structures are manipulated, and targeted disruption of genes for biosynthetic enzymes in animals (mouse, zebrafish, Drosophila, and Caenorhabditis elegans) followed by phenotype analysis. Whereas some protein ligands appear to require strictly defined HS structure, others bind to variable saccharide domains without apparent dependence on distinct saccharide sequence. These findings raise intriguing questions concerning the functional significance of regulation in HS biosynthesis and the potential for development of therapeutics targeting HS-protein interactions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amyloid; biosynthesis; cancer; cytokines; heparan sulfate; heparin; inflammation; proteoglycan

Mesh:

Substances:

Year:  2016        PMID: 27241222     DOI: 10.1016/bs.ircmb.2016.02.009

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  73 in total

1.  Establishment and characterization of Drosophila cell lines mutant for heparan sulfate modifying enzymes.

Authors:  Eriko Nakato; Xin Liu; Inger Eriksson; Maki Yamamoto; Akiko Kinoshita-Toyoda; Hidenao Toyoda; Lena Kjellén; Jin-Ping Li; Hiroshi Nakato
Journal:  Glycobiology       Date:  2019-06-01       Impact factor: 4.313

Review 2.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 3.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

Review 4.  Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.

Authors:  Paul O'Callaghan; Xiao Zhang; Jin-Ping Li
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 5.  The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Authors:  Rana El Masri; Amal Seffouh; Hugues Lortat-Jacob; Romain R Vivès
Journal:  Glycoconj J       Date:  2016-11-03       Impact factor: 2.916

6.  Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts.

Authors:  Raffaella Belvedere; Valentina Bizzarro; Luca Parente; Francesco Petrella; Antonello Petrella
Journal:  Cell Adh Migr       Date:  2017-08-10       Impact factor: 3.405

7.  Drosophila Glypicans Regulate Follicle Stem Cell Maintenance and Niche Competition.

Authors:  Tsu-Yi Su; Eriko Nakato; Pui Yee Choi; Hiroshi Nakato
Journal:  Genetics       Date:  2018-04-09       Impact factor: 4.562

8.  Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified Enpep and Hs2st1 as Vascular Inflammatory Modulators.

Authors:  Olga Berillo; Sofiane Ouerd; Noureddine Idris-Khodja; Asia Rehman; Chantal Richer; Daniel Sinnett; Anne E Kwitek; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2020-11-09       Impact factor: 10.190

9.  Bi-allelic Pathogenic Variants in HS2ST1 Cause a Syndrome Characterized by Developmental Delay and Corpus Callosum, Skeletal, and Renal Abnormalities.

Authors:  Pauline E Schneeberger; Leonie von Elsner; Emma L Barker; Peter Meinecke; Iris Marquardt; Malik Alawi; Katharina Steindl; Pascal Joset; Anita Rauch; Petra J G Zwijnenburg; Marjan M Weiss; Catherine L R Merry; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

Review 10.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.